Juvenile idiopathic arthritis(JIA) is a common connective tissue disease in children, mainly characterized by chronic arthritis and often accompanied by systemic damage. The main therapeutic goals of JIA are to suppress symptoms and improve the quality of life of children. Conventional synthetic disease-modifying anti-rheumatic drugs, glucocorticoids, and nonsteroidal anti-inflammatory drugs are important components of JIA treatment, but long-term use is often associated with many adverse reactions. Since the 21st century, biological agents and small molecule targeted drugs have greatly improved the prognosis of children with JIA through precise regulation of immune responses. This article systematically reviewed the development history of JIA treatment regimens and the future research directions have been prospectively discussed, aiming to provide reference for clinical practice.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |